- Arsanis Appoints David Mantus as Executive Vice President, Regulatory Affairs
- BOSTON and VIENNA, Nov. 4, 2015 /PRNewswire/ -- Arsanis, Inc., a development-stage biopharmaceutical company focused on monoclonal antibody therapeutics for severe infectious diseases, today announced that David Mantus, Ph.
- Arsanis Appoints Michael P. Gray as Chief Financial Officer and Chief Business
- Mr. Gray joins an experienced management team with a track record of success in infectious diseases, including: Eszter Nagy, MD, PhD, Arsanis co-founder and chief scientific officer; René Russo, PharmD, BCPS, chief development officer; David Mantus, ...
Mantus is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Mantus books and related discussion.
Suggested News Resources
Related searchesdream symbol run
tsavo east national park mudanda rock
atenolol pharmacology and indications
cricket other roles
mohawk language grammar